NPS Pharmaceuticals (NPSP) Names Dr. Tony Coles As CEO

May 12, 2006 2:11 PM EDT
Get Alerts NPSP Hot Sheet
Price: $45.97 --0%

Overall Analyst Rating:
    BUY (= Flat)

Trade Now! 
Join SI Premium – FREE
NPS Pharmaceuticals (Nasdaq: NPSP) announced that its board of directors has named company COO and president Dr. Tony Coles as its chief executive officer, succeeding Dr. Hunter Jackson who stepped down as NPS chairman and CEO.

Dr. Coles joined NPS in November 2005 as part of a planned transition, following Dr. Jackson's announcement that he would step down as chairman and CEO. Dr. Coles was appointed to his new post yesterday during the board of directors meeting in Parsippany, NJ. Dr. Jackson will remain on the NPS board of directors.

You May Also Be Interested In

Related Categories

Management Changes